Sodium zirconium cyclosilicate for hyperkalemia: a collateral acid-base benefit?

Nephrol Dial Transplant. 2021 Apr 26;36(5):756-760. doi: 10.1093/ndt/gfaa241.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Hyperkalemia* / drug therapy
  • Potassium
  • Silicates

Substances

  • Silicates
  • sodium zirconium cyclosilicate
  • Potassium